These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15096073)

  • 1. The cost consequences of treatment-resistant depression.
    Russell JM; Hawkins K; Ozminkowski RJ; Orsini L; Crown WH; Kennedy S; Finkelstein S; Berndt E; Rush AJ
    J Clin Psychiatry; 2004 Mar; 65(3):341-7. PubMed ID: 15096073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of treatment-resistant depression on health care utilization and costs.
    Crown WH; Finkelstein S; Berndt ER; Ling D; Poret AW; Rush AJ; Russell JM
    J Clin Psychiatry; 2002 Nov; 63(11):963-71. PubMed ID: 12444808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs associated with changes in antidepressant treatment in a managed care population with major depressive disorder.
    Schultz J; Joish V
    Psychiatr Serv; 2009 Dec; 60(12):1604-11. PubMed ID: 19952150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients.
    Li G; Zhang L; DiBernardo A; Wang G; Sheehan JJ; Lee K; Reutfors J; Zhang Q
    PLoS One; 2020; 15(9):e0238843. PubMed ID: 32915863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical expenditures associated with major depressive disorder among privately insured working-age adults with diagnosed diabetes in the United States, 2008.
    Shrestha SS; Zhang P; Li R; Thompson TJ; Chapman DP; Barker L
    Diabetes Res Clin Pract; 2013 Apr; 100(1):102-10. PubMed ID: 23490596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost burden of treatment resistance in patients with depression.
    Gibson TB; Jing Y; Smith Carls G; Kim E; Bagalman JE; Burton WN; Tran QV; Pikalov A; Goetzel RZ
    Am J Manag Care; 2010 May; 16(5):370-7. PubMed ID: 20469957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intent-to-treat analysis of health care expenditures of patients treated with atypical antipsychotics as adjunctive therapy in depression.
    Jing Y; Kalsekar I; Curkendall SM; Carls GS; Bagalman E; Forbes RA; Hebden T; Thase ME
    Clin Ther; 2011 Sep; 33(9):1246-57. PubMed ID: 21840058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.
    Wade AG; Fernández JL; François C; Hansen K; Danchenko N; Despiegel N
    Pharmacoeconomics; 2008; 26(11):969-81. PubMed ID: 18850765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental Health Care Burden of Treatment-Resistant Depression Among Commercial, Medicaid, and Medicare Payers.
    Shrestha A; Roach M; Joshi K; Sheehan JJ; Goutam P; Everson K; Heerlein K; Jena AB
    Psychiatr Serv; 2020 Jun; 71(6):593-601. PubMed ID: 32237982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression.
    Bosmans JE; Hermens ML; de Bruijne MC; van Hout HP; Terluin B; Bouter LM; Stalman WA; van Tulder MW
    J Affect Disord; 2008 Nov; 111(1):106-12. PubMed ID: 18342952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis.
    Simpson KN; Welch MJ; Kozel FA; Demitrack MA; Nahas Z
    Adv Ther; 2009 Mar; 26(3):346-68. PubMed ID: 19330495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One size fits some: the impact of patient treatment attitudes on the cost-effectiveness of a depression primary-care intervention.
    Pyne JM; Rost KM; Farahati F; Tripathi SP; Smith J; Williams DK; Fortney J; Coyne JC
    Psychol Med; 2005 Jun; 35(6):839-54. PubMed ID: 15997604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression.
    Nguyen KH; Gordon LG
    Value Health; 2015 Jul; 18(5):597-604. PubMed ID: 26297087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder.
    Taneja C; Papakostas GI; Jing Y; Baker RA; Forbes RA; Oster G
    Ann Pharmacother; 2012 May; 46(5):642-9. PubMed ID: 22550279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotherapy and pharmacotherapy in depression.
    Powers RH; Kniesner TJ; Croghan TW
    J Ment Health Policy Econ; 2002 Dec; 5(4):153-61. PubMed ID: 14578549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study.
    Valuck RJ; Libby AM; Sills MR; Giese AA; Allen RR
    CNS Drugs; 2004; 18(15):1119-32. PubMed ID: 15581382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The health value and cost of care for major depression.
    Watkins KE; Burnam MA; Orlando M; Escarce JJ; Huskamp HA; Goldman HH
    Value Health; 2009; 12(1):65-72. PubMed ID: 19911440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study).
    Rubio-Valera M; Beneitez I; Peñarrubia-María MT; Luciano JV; Mendive JM; McCrone P; Knapp M; Sabés-Figuera R; Kocyan K; García-Campayo J; Serrano-Blanco A
    BMC Psychiatry; 2015 Mar; 15():63. PubMed ID: 25885818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The economic impact of depression: resistance or severity?
    Fostick L; Silberman A; Beckman M; Spivak B; Amital D
    Eur Neuropsychopharmacol; 2010 Oct; 20(10):671-5. PubMed ID: 20624674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant treatment patterns and costs among US employees.
    Birnbaum H; Greenberg PE; Tang J; Hsieh M; Wu EQ; Amand C; Ben-Hamadi R
    J Med Econ; 2009 Mar; 12(1):36-45. PubMed ID: 19450063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.